Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature

By sjmartinez • January 2, 2025

Barghi A, Noveir SD, Mainwaring W, Milani-Nejad N, Bernet L. Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature. Int J Dermatol. 2024 Dec 30. doi: 10.1111/ijd.17626. Epub ahead of print. PMID: 39739856.

Tags: bullous pemphigoid, Dermatology, DGSOM Student, Dupilumab, eosinophilic annular erythema, immune checkpoint inhibitor, pembrolizumab, Publications

Emergency vs. Outpatient Care for Pediatric Atopic Dermatitis: A Population-Based Study of Sociodemographic Factors and Healthcare Utilization

Yamamoto RK, Tolson HC, Hao A, Kikuchi R, Sadrolashrafi K, Guo L, Bilimoria SN, Yee D, Armstrong AW. Emergency vs. Outpatient Care for Pediatric Atopic[...]

Beyond Universalis: eyebrow and eyelash loss in patients with alopecia areata

Fu J, Goh C. Beyond Universalis: eyebrow and eyelash loss in patients with alopecia areata. Br J Dermatol. 2025 Apr 11:ljaf139. doi: 10.1093/bjd/ljaf139. Epub ahead[...]

Measles Resurgence: What Every Dermatologist Should Know

Freeman E, Li C, Castillo D, Ahuja S, Chiu YE, Elewski B, Goh C, Hu J, Rosmarin D, Trinidad J, Rosenbach M. Measles Resurgence: What[...]